CBIO earnings: a positive outcome, +19.3%

On November 9, 2022, CRESCENT BIOPHARMA, INC. reached its earnings. The result was a positive outcome, and the stock moved +19.3% in the window around the event. It had already run +8.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.